Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Johan Van den Bogaerde"'
Autor:
Rupert W. Leong, Sudarshan Paramsothy, Hazel M. Mitchell, Michael A. Kamm, Watson Ng, Johan van den Bogaerde, Wei Xuan, Alissa Walsh, Enmoore Lin, Douglas Samuel, Ramesh Paramsothy, Nadeem O. Kaakoush, Thomas J. Borody, Susan J. Connor
Publikováno v:
The Lancet. 389:1218-1228
Summary Background The intestinal microbiota is implicated in the pathogenesis of ulcerative colitis. Faecal microbiota transplantation is a novel form of therapeutic microbial manipulation, but its efficacy in ulcerative colitis is uncertain. We aim
Autor:
Douglas Samuel, Hazel M. Mitchell, Alissa Walsh, Watson Ng, Thomas J. Borody, Sudarshan Paramsothy, Nandan P. Deshpande, Jeremiah J. Faith, Rupert W. Leong, Susan J. Connor, Jose C. Clemente, Marc R. Wilkins, Nadeem O. Kaakoush, Ramesh Paramsothy, Jean-Frederic Colombel, Enmoore Lin, Michael A. Kamm, Shaun Nielsen, Johan van den Bogaerde
Publikováno v:
Gastroenterology. 156(5)
Background & Aims Fecal microbiota transplantation (FMT) can induce remission in patients with ulcerative colitis (UC). In a randomized controlled trial of FMT in patients with active UC, we aimed to identify bacterial taxonomic and functional factor
Publikováno v:
The Medical journal of Australia. 209(7)
The gastrointestinal microbiota is emerging as a central factor in the pathogenesis of a range of gastrointestinal and hepatic disorders. Epidemiological studies, and experimental studies in animals and humans, have highlighted a likely causative rol
Publikováno v:
Expert Review of Gastroenterology & Hepatology. 7:689-700
Surgery has been a mainstay of therapy for Crohn's disease for a long time, essentially as a consequence of the fairly modest efficacy of traditional medications such as immunomodulators, antibiotics and 5-ASA, especially in severe cases. However, in
Autor:
Jean-Frederic Colombel, Enmoore Lin, Michael A. Kamm, Hazel M. Mitchell, Nadeem O. Kaakoush, Douglas Samuel, Sudarshan Paramsothy, Thomas J. Borody, Rupert W. Leong, Ramesh Paramsothy, Alissa Walsh, Shaun Nielsen, Jeremiah J. Faith, Marc R. Wilkins, Susan J. Connor, Nandan P. Deshpande, Johan van den Bogaerde, Wa Sang Watson Ng, Jose C. Clemente
Publikováno v:
Gastroenterology. 154:S-35
Autor:
Enmoore Lin, Nadeem O. Kaakoush, Rupert W. Leong, Sudarshan Paramsothy, Sarah Finlayson, Johan van den Bogaerde, Hazel M. Mitchell, Douglas Samuel, Watson Ng, Thomas J. Borody, Alissa Walsh, Michael A. Kamm, Susan J. Connor
Publikováno v:
Inflammatory bowel diseases. 21(7)
Background Increasing demand for fecal microbiota transplantation (FMT) has created a need for stool banks sourced from long-term healthy donors. Here, we describe our experience in recruiting and screening fecal donors. Methods Mailbox, newspaper, a
Autor:
Sudarshan Paramsothy, Johan van den Bogaerde, Alissa Walsh, Michael A. Kamm, Rupert W. Leong, Hazel M. Mitchell, Nadeem O. Kaakoush, Thomas J. Borody, Susan J. Connor, Douglas Samuel, Watson Ng
Publikováno v:
World journal of gastroenterology. 21(38)
© 2015 Baishideng Publishing Group Inc. All rights reserved. AIM: To explore gastroenterologist perceptions towards and experience with faecal microbiota transplantation (FMT). METHODS: A questionnaire survey consisting of 17 questions was created t
Autor:
Ramesh Paramsothy, Wa Sang Watson Ng, Nadeem O. Kaakoush, Douglas Samuel, Wei Xuan, Thomas J. Borody, Hazel M. Mitchell, Michael A. Kamm, Sudarshan Paramsothy, Susan J. Connor, Johan van den Bogaerde, Enmoore Lin, Rupert W. Leong, Alissa Walsh
Publikováno v:
Gastroenterology. 150:S122-S123
Publikováno v:
Expert review of clinical immunology. 10(2)
In the last several years many biologic agents for Crohn's disease have been developed. Due to their unique molecular specificity biologics are de facto indicators of the ultimate significance of the molecule targeted by the biologic itself. Here, we
Autor:
Johan Van den Bogaerde
Publikováno v:
Current Opinion on Therapeutic Patents. 2:463-476
(1992). Overview: Strategies for the Prevention of Graft Rejection. Current Opinion on Therapeutic Patents: Vol. 2, No. 4, pp. 463-476.